Literature DB >> 2007320

Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans.

A Hedman1, B Angelin, A Arvidsson, O Beck, R Dahlqvist, B Nilsson, M Olsson, K Schenck-Gustafsson.   

Abstract

The interaction between digoxin and verapamil was studied in six patients (mean age +/- SD, 61 +/- 5 years) with chronic atrial fibrillation. The effects of adding verapamil (240 mg/day) on steady-state plasma concentrations and renal and biliary clearances of digoxin were studied in a crossover manner. The biliary clearance of digoxin was determined by a duodenal perfusion technique. Verapamil induced a 44% increase in steady-state plasma concentrations of digoxin, from 0.80 +/- 0.24 to 1.15 +/- 0.40 nmol/L (p less than 0.01). The biliary clearance of digoxin decreased by 43%, from 187 +/- 89 to 101 +/- 55 ml/min (p less than 0.05), in the presence of verapamil, whereas the renal clearance was unaffected (153 +/- 31 versus 173 +/- 51 ml/min; difference not significant). Our results indicate that the main inhibitory effect of verapamil on digoxin elimination is on the biliary route.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007320     DOI: 10.1038/clpt.1991.26

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

1.  A Generic Model for Quantitative Prediction of Interactions Mediated by Efflux Transporters and Cytochromes: Application to P-Glycoprotein and Cytochrome 3A4.

Authors:  Michel Tod; S Goutelle; N Bleyzac; L Bourguignon
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

Review 2.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

Review 3.  Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.

Authors:  R N Brogden; P Benfield
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

4.  A sandwiched microarray platform for benchtop cell-based high throughput screening.

Authors:  Jinhui Wu; Ian Wheeldon; Yuqi Guo; Tingli Lu; Yanan Du; Ben Wang; Jiankang He; Yiqiao Hu; Ali Khademhosseini
Journal:  Biomaterials       Date:  2010-10-20       Impact factor: 12.479

5.  The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.

Authors:  R Sandström; T W Knutson; L Knutson; B Jansson; H Lennernäs
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 6.  Methods to evaluate biliary excretion of drugs in humans: an updated review.

Authors:  Giulia Ghibellini; Elaine M Leslie; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

7.  Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.

Authors:  A Hedman; B Angelin; A Arvidsson; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 8.  Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.

Authors:  P D Pearigen; N L Benowitz
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 9.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

10.  Inhibition by basic drugs of digoxin secretion into human bile.

Authors:  A Hedman
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.